phenytoin has been researched along with Parkinson Disease, Secondary in 3 studies
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kryzhanovskiĭ, GN | 1 |
| Atadzhanov, MA | 1 |
| Kucherianu, VG | 1 |
| Ferrari, MD | 1 |
| Peeters, EA | 1 |
| Haan, J | 1 |
| Roos, RA | 1 |
| Vermey, P | 1 |
| de Wolff, FA | 1 |
| Buruma, OJ | 1 |
| Goñi, M | 1 |
| Jimenez, M | 1 |
| Feijoo, M | 1 |
3 other studies available for phenytoin and Parkinson Disease, Secondary
| Article | Year |
|---|---|
[Effects of difenin on experimental parkinsonian syndrome].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Caudate Nucleus; Male; Motor Cortex; Parkinso | 1990 |
Cytochrome P450 and Parkinson's disease. Poor parahydroxylation of phenytoin.
Topics: Aged; Cytochrome P-450 Enzyme System; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondar | 1990 |
Parkinsonism induced by phenytoin.
Topics: Aged; Carbamazepine; Gait; Humans; Male; Parkinson Disease, Secondary; Phenytoin | 1985 |